基于CRISPR-Cas13a的结核病分子技术的临床诊断价值
Kai Wu1, Zhenyao Wu1, Xiongjie Li2
1Department of Thoracic Surgery, Jianghan Oilfield General Hospital, No. T32 Ankang Road, Qianjiang, 433124, Hubei, China.
Irish journal of medical science
|September 19, 2024
概括
在临床环境中,CRISPR-Cas13a分子技术显示出结核病 (TB) 的高诊断价值. 这种测试是推用于疑似结核病患者的初始查,比传统方法更准确.
科学领域:
- 分子诊断学 分子诊断学
- 传染病检测 发现 传染病检测
- 生物技术应用 生物技术应用
背景情况:
- 结核病 (TB) 诊断依赖于各种方法,其准确性各不相同.
- 需要新的分子技术来改善早期和准确的结核病检测.
- CRISPR-Cas13a为核酸检测提供了一个有前途的平台.
研究的目的:
- 评估CRISPR-Cas13a技术对结核病的临床诊断价值.
- 为了比较CRISPR-Cas13a测定与已建立的结核病诊断方法的性能.
- 评估CRISPR-Cas13a对可疑结核病例的初始查的有用性.
主要方法:
- 189名可疑结核病患者的队列接受了酸速染色,MGIT 960培养,Xpert MTB/RIF和CRISPR-Cas13a测定.
- 最终的临床诊断作为比较试验性能的黄金标准.
- MGIT 960培养被用作评估CRISPR-Cas13a一致性的二级黄金标准.
主要成果:
- 与酸速染色相比,CRISPR-Cas13a测定显示出更高的灵敏度,负预测值和准确性.
- 克里斯帕-Cas13a,MGIT 960和Xpert MTB/RIF的诊断性能优于酸性染色 (p < 0.05).
- 在CRISPR-Cas13a和MGIT 960培养之间观察到中等一致性 (kappa = 0.666).
结论:
- 应用于支气管支气管洗液的CRISPR-Cas13a测定显示了结核病诊断的显著临床价值.
- 该技术适用于疑似结核病患者的初始查.
- 在结核病分子诊断方面,CRISPR-Cas13a代表了一项有价值的进步.
相关概念视频
Pulmonary Tuberculosis IV
134
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
134
CRISPR
49.8K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
49.8K
CRISPR and crRNAs
16.9K
Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
16.9K


